Resultados de la búsqueda 1021-1030 of 10597 for autoimmune hepatitis
Venetoclax is FDA approved for the treatment of CLL and SLL. The drug combination of acalabrutinib, durvalumab, and venetoclax is experimental and isn't ...
The overall objective of this study is to define genes causing cystic kidney disease and to determine the degree to which variants at these cystic kidney ...
The purpose of this study is to determine whether transverse/sigmoid sinus junction stenting reduces the risk of recurrent cerebrospinal fluid (CSF) leak in ...
Red blood cell count: An unrecognized risk factor for nonalcoholic fatty liver disease. Frontiers in Endocrinology. 2021; doi:10.3389/fendo.2021.760981. Jan ...
tis C, Colangitis esclerosante primaria, Hepatitis ... Engineering stem cells to treat liver disease ... A Mayo Clinic collaboration studies engineered stem cells ...
Liver disease: How medications can harm the liver · Marihuana medicinal · Mitos sobre las causas del cáncer · Reducción progresiva del uso de opioides: cuándo y ...
This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...
The purpose of this study is to determine how well tafasitamab, lenalidomide and venetoclax work in treating patients with mantle cell lymphoma that has ...
Trasplante de hígado, Colangitis esclerosante primaria, Hepatitis C, Hepatitis B, carcinoma hepatocelular, Cirrosis bil...iar primaria, Hígado graso no ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?